Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
28.59
+0.89 (3.21%)
At close: Sep 16, 2026, 4:00 PM EDT
28.56
-0.03 (-0.10%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Biodesix Employees
Biodesix had 334 employees as of December 31, 2025. The number of employees increased by 61 or 22.34% compared to the previous year.
Employees
334
Change (1Y)
61
Growth (1Y)
22.34%
Revenue / Employee
$308,201
Profits / Employee
-$83,120
Market Cap
301.66M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 334 | 61 | 22.34% |
| Dec 31, 2024 | 273 | 56 | 25.81% |
| Dec 31, 2023 | 217 | -28 | -11.43% |
| Dec 31, 2022 | 245 | 27 | 12.39% |
| Dec 31, 2021 | 218 | 18 | 9.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 1,002 |
| Burning Rock Biotech | 667 |
| Freenome | 381 |
| MDxHealth | 364 |
| Personalis | 260 |
BDSX News
- 2 days ago - Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings - GlobeNewsWire
- 13 days ago - Biodesix to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Biodesix Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 5 weeks ago - Biodesix price target raised to $35 from $27 at Canaccord - TheFly
- 5 weeks ago - Biodesix price target raised to $27 from $26 at H.C. Wainwright - TheFly
- 6 weeks ago - Biodesix Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Biodesix Earnings release: Q2 2026 - Filings
- 6 weeks ago - Biodesix Quarterly report: Q2 2026 - Filings